Tyrosine kinase inhibitors drugs

Part 0 - Goal: To gather data types on tyrosine kinase inhibitors (TKIs) (drugs that target [receptor] tyrosine kinases (RTKs)) to treat cancer

A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of

Outline the different types of tyrosine kinase inhibitor (TKI) drugs and the currently available TKIs. Describe the mechanism of action of tyrosine kinase inhibitors. Summarize the indications and contraindications for each type of tyrosine kinase inhibitor.

Tyrosine Kinase Inhibitors ; Gilteritinib, An AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia. ; Erdafitinib, A

The targeted drugs used to treat GISTs are called tyrosine kinase inhibitors (TKIs), because they target proteins that are tyrosine kinases, such as KIT and

If necessary, the levothyroxine dose has to be adjusted. Tyrosine kinase inhibitors: Tyrosine kinase inhibitors (e.g. imatinib, sunitinib) may decrease the

The targeted therapy drugs used for CML are called tyrosine kinase inhibitors (TKIs). They work by turning off the abnormal tyrosine kinase protein made by the

Tyrosine kinase inhibitors – For most people, CML is treated with an oral medication, called a tyrosine kinase inhibitor (TKI). This medication

Tyrosine kinase inhibitors (TKIs) block chemical messengers (enzymes) called tyrosine kinases. Tyrosine kinases help to send growth signals in cells. So